Fidelity Investments’s Biomerica BMRA Stock Holding History

Fidelity Investments’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$146	Buy	+83	New	+$178	﹤0.01%	5381
2024 Q4	–	Sell	-6	Closed	-$16	–	5560
2024 Q3	$16	Buy	+6	New	+$17	﹤0.01%	5381
2021 Q3	–	Hold	0	–	–	–	4359
2021 Q2	–	Hold	0	–	–	–	4257

Other funds holding BMRA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Fidelity Investments's BMRA Position: Q2 2026 in Review

Fidelity Investments opened a new position in Biomerica (BMRA) in Q2 2026: 83 shares worth $146. The stake represents ﹤0.01% of the portfolio and ranks #5381 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in BMRA as recently as Q3 2024.

Fidelity Investments first reported a position in BMRA in Q3 2024 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold BMRA as of Q2 2026.

Fidelity Investments held 83 shares of Biomerica worth $146 as of Q2 2026.
Biomerica was a new Fidelity Investments position in Q2 2026.
Biomerica made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5381 holding.
Fidelity Investments first reported a position in Biomerica in Q3 2024 and has held it in 2 quarters since.
20 funds tracked by Wall St. Rank held Biomerica as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.